DrugPatentWatch Database Preview
Details for Patent: 9,486,526
» See Plans and Pricing
Which drugs does patent 9,486,526 protect, and when does it expire?
Patent 9,486,526 protects TRADJENTA and is included in one NDA.
This patent has forty patent family members in twenty-three countries.
Summary for Patent: 9,486,526
| Title: | Treatment for diabetes in patients inappropriate for metformin therapy |
| Abstract: | The present invention relates to the finding that certain DPP-4 inhibitors are particularly suitable for treating and/or preventing metabolic diseases, particularly diabetes, in patients for whom metformin therapy is inappropriate due to intolerability or contraindication against metformin. |
| Inventor(s): | Dugi; Klaus (Dresden, DE), Graefe-Mody; Eva Ulrike (Ingelheim am Rhein, DE), Harper; Ruth (Reading, GB), Woerle; Hans-Juergen (Munich, DE) |
| Assignee: | Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE) |
| Application Number: | 14/294,630 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,486,526 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 9,486,526
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Boehringer Ingelheim | TRADJENTA | linagliptin | TABLET;ORAL | 201280-001 | May 2, 2011 | RX | Yes | Yes | Start Trial | Start Trial | METHOD OF TREATING TYPE 2 DIABETES MELLITUS IN PATIENTS WITH SEVERE CHRONIC RENAL IMPAIRMENT AND WHO ARE INELIGIBLE FOR METFORMIN THERAPY BY ADMINISTERING LINAGLIPTIN | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 9,486,526
International Family Members for US Patent 9,486,526
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 072920 | Start Trial | |||
| Australia | 2009279085 | Start Trial | |||
| Canada | 2732803 | Start Trial | |||
| Chile | 2011000259 | Start Trial | |||
| China | 102105145 | Start Trial | |||
| China | 103550219 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
